After Pfizer Inc. coronavirus vaccine got a positive review from a panel of experts advising the Food & Drug Administration, the pharma company increased its quarterly dividend.
Yesterday, a 17-4 vote endorsed the covid-19 vaccine jointly developed by Pfizer and BioNTech. The FDA will move ahead with its Emergency Use Authorization approval later today.
Pfizer announced that it would pay out a first quarter dividend of 39 cents per share, which is +3% higher than its previous level.
“Our commitment to returning capital to shareholders is strong and the dividend increase reflects our continued confidence in the business and in our scientific pipeline,” said CEO Albert Bourla. “It also reinforces that our focus on creating meaningful value for patients benefits all our stakeholders.